Your browser doesn't support javascript.
loading
Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing.
Kesselheim, Aaron S; Woloshin, Steven; Lu, Zhigang; Tessema, Frazer A; Ross, Kathryn M; Schwartz, Lisa M.
Afiliação
  • Kesselheim AS; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Woloshin S; The Center for Medicine and the Media, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire.
  • Lu Z; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Tessema FA; Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Ross KM; The American Board of Internal Medicine, Philadelphia, Pennsylvania.
  • Schwartz LM; The Center for Medicine and the Media, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire.
JAMA Intern Med ; 179(5): 707-709, 2019 05 01.
Article em En | MEDLINE | ID: mdl-30667474
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Padrões de Prática Médica / Atitude do Pessoal de Saúde / Aprovação de Drogas / Uso Off-Label Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Padrões de Prática Médica / Atitude do Pessoal de Saúde / Aprovação de Drogas / Uso Off-Label Idioma: En Ano de publicação: 2019 Tipo de documento: Article